HOME >> BIOLOGY >> NEWS
University of Minnesota receives NSF grant to sequence legume genome

MINNEAPOLIS / ST. PAUL--The University of Minnesota has received $10.8 million from the National Science Foundation (NSF) for a multi-institution initiative to sequence the genome of a model legume known by its scientific name, Medicago truncatula (the barrel medic). Medicago truncatula is the third plant genome to be sequenced; only Arabidopsis--a plant widely studied as a model green plant--and rice have been sequenced to date. Medicago was given such high priority because it provides an excellent experimental system to study agriculturally important legumes like soybeans, mung beans, chickpeas, cowpeas, and lentils, crops that constitute the major source of protein for people throughout the developing world. Alfalfa is also a legume and is a major source of protein for foraging cattle and a close relative of Medicago truncatula.

Nevin Young, a professor with a joint appointment in the departments of plant pathology and plant biology in the university's College of Agricultural, Food and Environmental Sciences, will lead the work, which is part of NSF's plant genome research program.

Legumes acquire their high protein content by virtue of their ability to produce their own fertilizer through a process known as nitrogen fixation. Legumes also produce many novel compounds with health-promoting properties, such as anti-cancer activity.

"Legumes are responsible for a majority of the biologically generated nitrogen in the world, especially in agriculture," said Young. That is, before the expensive, energy-intensive process of commercial fertilizer production was invented, agriculture worldwide depended on legumes to supply the nitrogen needed to make protein. Legumes perform this feat with the help of bacteria that infect their roots and form specialized structures called nodules. Within nodules, nitrogen gas from the air is converted into a form that living organisms can use to make amino acids and proteins.

The special compounds le
'"/>

Contact: Deane Morrison
morri029@umn.edu
612-624-2346
University of Minnesota
20-Oct-2003


Page: 1 2 3

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... (PRWEB) , ... July 01, 2020 , ... ... presented its phase 1a findings of Neihulizumab, a biologic for the treatment of ... June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson ...
(Date:6/28/2020)... BASEL, Switzerland (PRWEB) , ... ... ... leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that ... oncology company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable ... testing operations in the fight against the COVID-19 pandemic in Zambia. , One ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... year to date growth of 40% in 2020, despite many obstacles created as ... MedShift aims to increase revenue for its partnered medical practices and medical manufacturers ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... today announced the company has entered a license agreement with Roswell Park Comprehensive ... globally exclusive rights to Roswell Park intellectual property surrounding a novel medical device ...
(Date:6/23/2020)... YORK (PRWEB) , ... June 22, 2020 , ... ... its lead glutamine antagonist, DRP-104, will be presented June 22-24 during the American ... effects of DRP-104; and, the other profiles the potent, consistent single agent activity ...
(Date:6/11/2020)... GREENBELT, Md. (PRWEB) , ... June 09, 2020 ... ... announced today the release of the NEON Micro-Tracer Solution, a highly ... to the COVID-19 virus in the workplace. Contact tracing, a core disease control ...
Breaking Biology Technology:
Cached News: